Search

everythinglearnresearchcommunity

for

Search:↓

Examining scalp biopsies in different ways helps better diagnose hair loss types.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Moxibustion may help improve ovarian function by changing androgen levels.

Insulin might be involved in causing hair loss and acne.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Women with PCOS have altered brain structure and reduced cognitive performance.

Skin aging reflects overall body aging and can indicate internal health conditions.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

PCOS-related infertility is managed with lifestyle changes and medications.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

Combining different drugs can improve hair loss treatment.

Minoxidil effectively treats patterned hair loss in both males and females.

Combining plant extracts with nanotechnology may improve hair loss treatments.

High TNF-α levels may increase hair loss risk after PRP therapy.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

Oral lichen planus is not linked to sex hormone levels.

Non-compliance with PCOS medication worsens symptoms and highlights the need for better patient support and education.